Discover new national payment amounts for NOC drugs

Why This Topic Matters

CMS payment updates can affect how certain unclassified drugs are billed, reimbursed, and reviewed by carriers. Understanding the scope of the update helps billing teams and specialty practices stay aware of payment limits and carrier discretion without assuming coverage is guaranteed.

Article Sections

1. CMS national payment amounts for selected NOC drugs

   This section introduces the CMS update and the broader context for payment ceilings applied to selected unclassified drugs and biologics.

2. Carrier discretion and coverage context

   This section discusses the relationship between payment limits and carrier coverage decisions, including the role of Medicare policy language.

3. Specialty practice and billing considerations

   This section addresses the article’s specialty-specific comments and general reporting considerations for drug claims, including issues raised by oncology and urology practices.

4. Drug wastage and NOC list overview

   This section summarizes general guidance on wastage billing and references the overall list of unclassified drugs and biologics mentioned by CMS.